UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

PloS one, 2018-08, Vol.13 (8), p.e0201832-e0201832

2018

Volltextzugriff (PDF)

Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation

Blood, 2013-08, Vol.122 (9), p.1610-1620

2013

Volltextzugriff (PDF)

Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity

Journal of hematology and oncology, 2020-11, Vol.13 (1), p.160-160, Article 160

2020

Volltextzugriff (PDF)

780 ALTA-002, a SIRPα-directed TLR9 agonist antibody conjugate activates myeloid cells and promotes anti-tumor immunity

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A815-A815

2021

Volltextzugriff (PDF)

Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5‑a]pyrazines as ATR Inhibitors

ACS medicinal chemistry letters, 2015-01, Vol.6 (1), p.37-41

2015

Volltextzugriff (PDF)

615 Targeted immune cell activation by systemic delivery of toll-like receptor 9 agonist antibody conjugates induce potent anti-tumor immunity

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A369-A370

2020

Volltextzugriff (PDF)

Abstract 3629: BLZ945, a selective c-fms (CSF-1R) kinase inhibitor for the suppression of tumor-induced osteolytic lesions in bone

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3629-3629

2010

Volltextzugriff (PDF)

Assessing and mitigating the interference of ALX148, a novel CD47 blocking agent, in pretransfusion compatibility testing

Transfusion (Philadelphia, Pa.), 2020-10, Vol.60 (10), p.2399-2407

2020

Volltextzugriff (PDF)

Mutational evidence supporting the involvement of tripartite residues his183, asp185, and his243 in Streptomyces clavuligerus deacetoxycephalosporin C synthase for catalysis

Bioscience, biotechnology, and biochemistry, 2000-04, Vol.64 (4), p.828-832

2000

Volltextzugriff (PDF)

Abstract 1721: TAC-001, a toll-like receptor 9 (TLR9) agonist antibody conjugate targeting B cells, promotes anti-tumor immunity and favorable safety profile following systemic administration in preclinical models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1721-1721

2021

Volltextzugriff (PDF)

Towards a Model of the Acceptance of Information Technology Learning: The Role of Extrinsic and Intrinsic Motivation

International Journal of Information Processing and Management, 2011-10, Vol.2 (4), p.22-33

2011

Volltextzugriff (PDF)

ALX148 Enhances the Depth and Durability of Response to Multiple AML Therapies

Blood, 2020-11, Vol.136 (Supplement 1), p.15-16

2020

Volltextzugriff (PDF)

Abstract 562: Antibodies to Sirpα enhance innate and adaptive immune responses to promote anti-tumor activity

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.562-562

2019

Volltextzugriff (PDF)

Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα

mAbs, 2019-08, Vol.11 (6), p.1036-1052

2019

Volltextzugriff (PDF)

Mobile Technology Dependence and Mobile Technostress

International journal of innovation and technology management, 2018-08, Vol.15 (4), p.1850039

2018

Volltextzugriff (PDF)

Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors

Journal of molecular biology, 2017-06, Vol.429 (11), p.1684-1704

2017

Volltextzugriff (PDF)

Abstract 6746: A B-cell targeted TLR9 agonist antibody conjugate potentiates cancer vaccine efficacy and rejuvenates vaccine responses in the elderly

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6746-6746

2024

Volltextzugriff (PDF)

A Model of Attitude toward Mobile Location-Based Services

Journal of quality assurance in hospitality & tourism, 2015-10, Vol.16 (4), p.414-437

2015

Volltextzugriff (PDF)

A Model of Customer Satisfaction and Retention for Hotels

Journal of quality assurance in hospitality & tourism, 2006-12, Vol.7 (3), p.1-23

2006

Volltextzugriff (PDF)

ALX148 Is a High Affinity Sirpα Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Preclinical Models

Blood, 2017-12, Vol.130, p.112-112

2017

Volltextzugriff (PDF)

Targeting the myeloid checkpoint receptor SIRP[alpha] potentiates innate and adaptive immune responses to promote anti-tumor activity

Journal of hematology and oncology, 2020-11, Vol.13 (1)

2020

Volltextzugriff (PDF)

Amino acid substitutions affecting protein solubility: high level expression of Streptomyces clavuligerus isopenicillin N synthase in Escherichia coli

Journal of Molecular Catalysis. B, Enzymatic, 1999-03, Vol.6 (3), p.133-143

1999

Volltextzugriff (PDF)

Assessing dimensions of organizational trust across cultures: A comparative analysis of U.S. and Indian full service hotels

International journal of hospitality management, 2011-06, Vol.30 (2), p.233-242

2011

Volltextzugriff (PDF)

Expression, purification and characterization of inactive and active forms of ERK2 from insect expression system

Protein expression and purification, 2015-06, Vol.110, p.172-179

2015

Volltextzugriff (PDF)

Abstract 5194: Pim2 is required for maintaining Multiple Myeloma cell proliferation through modulating mTORC1 pathway

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5194-5194

2013

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(200)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(225)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(83)
Humans
(71)
Male
(34)
Female
(31)
Animals
(19)
Biological And Medical Sciences
(19)
Computer Science
(18)
Technology
(18)
Biochemistry & Molecular Biology
(16)
Children
(14)
Computer Science, Cybernetics
(12)
Risk Factors
(12)
Aged
(11)
Social Sciences
(11)
Adult
(10)
Computer Science, Interdisciplinary Applications
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Gene Expression
(10)
Immunology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation

Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity

780 ALTA-002, a SIRPα-directed TLR9 agonist antibody conjugate activates myeloid cells and promotes anti-tumor immunity

Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5‑a]pyrazines as ATR Inhibitors

615 Targeted immune cell activation by systemic delivery of toll-like receptor 9 agonist antibody conjugates induce potent anti-tumor immunity

Abstract 3629: BLZ945, a selective c-fms (CSF-1R) kinase inhibitor for the suppression of tumor-induced osteolytic lesions in bone

Assessing and mitigating the interference of ALX148, a novel CD47 blocking agent, in pretransfusion compatibility testing

Mutational evidence supporting the involvement of tripartite residues his183, asp185, and his243 in Streptomyces clavuligerus deacetoxycephalosporin C synthase for catalysis

Abstract 1721: TAC-001, a toll-like receptor 9 (TLR9) agonist antibody conjugate targeting B cells, promotes anti-tumor immunity and favorable safety profile following systemic administration in preclinical models

Towards a Model of the Acceptance of Information Technology Learning: The Role of Extrinsic and Intrinsic Motivation

ALX148 Enhances the Depth and Durability of Response to Multiple AML Therapies

Abstract 562: Antibodies to Sirpα enhance innate and adaptive immune responses to promote anti-tumor activity

Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα

Mobile Technology Dependence and Mobile Technostress

Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors

Abstract 6746: A B-cell targeted TLR9 agonist antibody conjugate potentiates cancer vaccine efficacy and rejuvenates vaccine responses in the elderly

A Model of Attitude toward Mobile Location-Based Services

A Model of Customer Satisfaction and Retention for Hotels

ALX148 Is a High Affinity Sirpα Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Preclinical Models

Targeting the myeloid checkpoint receptor SIRP[alpha] potentiates innate and adaptive immune responses to promote anti-tumor activity

Amino acid substitutions affecting protein solubility: high level expression of Streptomyces clavuligerus isopenicillin N synthase in Escherichia coli

Assessing dimensions of organizational trust across cultures: A comparative analysis of U.S. and Indian full service hotels

Expression, purification and characterization of inactive and active forms of ERK2 from insect expression system

Abstract 5194: Pim2 is required for maintaining Multiple Myeloma cell proliferation through modulating mTORC1 pathway

Suchergebnisse filtern